Request for Information: FDA IT Infrastructure Services
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The U.S. Food and Drug Administration is conducting market research through a Request for Information to assess the availability of industry capabilities for FDA IT Infrastructure Services. This RFI is purely informational and does not constitute a solicitation, nor does it obligate the government to award any contract now or in the future. Responses are voluntary, and no financial compensation will be provided for the time or cost incurred in submitting information. The FDA will use the responses to determine whether sufficient sources exist to meet its technical and operational needs, but no selection or award decisions will be made based on this RFI. There will be no acknowledgment of submissions, no feedback provided to respondents, and no meetings held with interested parties, although the agency reserves the right to reach out for clarification if needed. All information submitted must not include proprietary, classified, confidential, or sensitive data, as the government may use any non-proprietary technical details in future solicitations without obligation or liability. Respondents should not infer any contractual relationship or rights from participation. The submission deadline is July 3, 2026, at 8:00 p.m. Eastern Time, and responses must be sent via email to Michelle Dacanay at michelle.dacanay@fda.hhs.gov; phone calls will not be accepted. The point of contact for secondary inquiries is Phillip Frame. The office administering this RFI is located in Rockville, Maryland, with the performance location in Silver Spring, Maryland. This effort is part of the FDA’s ongoing preparation for potentially issuing a future contract related to IT infrastructure support, but no solicitation is currently active.
General Info
Agency
NAICS
Place of Performance
Silver Spring, MD, 20903, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
The U.S. Food and Drug Administration (FDA) is issuing this Request for Information (RFI) as a means of conducting market research, pursuant to FAR Part 10 Market Research.
This is a REQUEST FOR INFORMATION (RFI) ONLY, not a Request for Quote (RFQ) and does not commit the Government to award a contract now or in the future.
The purpose of this RFI is to obtain information from industry based on the questions contained in this notice. Submission of any information in response to this market survey is purely voluntary and FDA welcomes responses from all interested parties; the Government assumes no financial responsibility for any costs incurred.
The FDA will use the results of the market research to determine if sources are capable of satisfying the agency's requirements exist based on the response received to the Government’s questions contained in this notice. The FDA does not intend to make a selection decision or award a contract on the basis of responses. Acknowledgement of receipt of responses will not be made, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold meetings concerning this RFI with any interested parties. However, FDA reserves the right to contact vendors if additional information is required.
Respondents will not receive individualized feedback on any suggestions or questions submitted. No basis for claims against the United States government shall arise as a result of a response to this request for information or from the United States government's use of such information. Proprietary, classified, confidential, or sensitive information should not be included in your response. The Federal Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
While the Government anticipates establishing a contract for the FDA IT Infrastructure Services which requires contractual support, A SOLICITATION IS NOT CURRENTLY AVAILABLE. The Government is not obligated and will not pay for any information received from potential sources as a result of this sources sought.
Email to: Michelle Dacanay, michelle.dacanay@fda.hhs.gov by the posted due date and time.
No phone calls will be accepted for this notice
See attachment for complete RFI information.